Publication
Article Metrics
Citations
Online attention
Structural basis for inhibition of human primase by arabinofuranosyl nucleoside analogues fludarabine and vidarabine
DOI:
10.1021/acschembio.9b00367
Authors:
Sandro
Holzer
(University of Cambridge)
,
Neil J.
Rzechorzek
(University of Cambridge)
,
Isobel R.
Short
(University of Cambridge)
,
Michael
Jenkyn-Bedford
(University of Cambridge)
,
Luca
Pellegrini
(University of Cambridge)
,
Mairi
Kilkenny
(University of Cambridge)
Co-authored by industrial partner:
No
Type:
Journal Paper
Journal:
Acs Chemical Biology
State:
Published (Approved)
Published:
September 2019
Diamond Proposal Number(s):
9537

Abstract: Nucleoside analogues are widely used in clinical practice as chemotherapy drugs. Arabinose nucleoside derivatives such as fludarabine are effective in the treatment of patients with acute and chronic leukemias and non-Hodgkin lymphomas. Although nucleoside analogues are generally known to function by inhibiting DNA synthesis in rapidly proliferating cells, the identity of their in vivo targets and mechanism of action are often not known in molecular detail. Here we provide a structural basis for arabinose nucleotide-mediated inhibition of human primase, the DNA-dependent RNA polymerase responsible for initiation of DNA synthesis in DNA replication. Our data suggest ways in which the chemical structure of fludarabine could be modified to improve its specificity and affinity towards primase, possibly leading to less toxic and more effective therapeutic agents.
Subject Areas:
Chemistry,
Biology and Bio-materials,
Medicine
Instruments:
I02-Macromolecular Crystallography
,
I04-1-Macromolecular Crystallography (fixed wavelength)
,
I24-Microfocus Macromolecular Crystallography
Other Facilities: SOLEIL
Added On:
09/09/2019 10:57
Documents:
kl5hhtnn5.pdf
Discipline Tags:
Non-Communicable Diseases
Health & Wellbeing
Cancer
Biochemistry
Genetics
Chemistry
Structural biology
Drug Discovery
Life Sciences & Biotech
Technical Tags:
Diffraction
Macromolecular Crystallography (MX)